Cagrilintide + semaglutide

Intervention2 papers1 findingPubChem 171397054PubChem 56843331ChEBI 167574

Outcomes

1

HbA1c

downin humans1−2%

1 study

Cagrilintide + semaglutide decreases HbA1c in humans (up to 2.0%).
Reviewtype 2 diabetes mellitus68 weeks
New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus · Diabetes therapy : research, treatment and education of diabetes and related disorders · 28 Sep 2026

Latest

2

Diabetes, Metabolic Syndrome and ObesityReview1 Oct

Recent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping Review

Diabetes TherapyReview29 Sep

New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus